Please wait while the formulary information is being retrieved.
LUMIFY (brimonidine tartrate)
- Ocular redness
0.025 % eye drops
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Buerger's disease
- Cerebrovascular disorder
- Depression
- Orthostatic hypotension
- Raynaud's phenomenon
LUMIFY (brimonidine tartrate)
- Ocular redness
- Conjunctival hyperemia
- Follicular conjunctivitis
- Headache disorder
- Ocular itching
- Ocular redness
- Allergic conjunctivitis
- Drowsy
- Eye tearing
- Fatigue
- Ocular irritation
- Xerostomia
More Frequent
Severe
Less Severe
- Blepharitis
- Blurred vision
- Chemosis
- Conjunctival hemorrhage
- Corneal erosion
- Depression
- Dizziness
- Eyelid edema
- Gastrointestinal irritation
- Hypertension
- Mucopurulent conjunctivitis
- Myalgias
- Nasal congestion
- Nausea
- Ocular discomfort
- Ocular pain
- Rhinitis
- Sneezing
- Syncope
- Visual changes
- Vomiting
- Conjunctival blanching
- Corneal staining
- Dry eye
- Dysgeusia
- Insomnia
- Muscle weakness
- Ocular crusting
- Palpitations
- Photophobia
- Symptoms of anxiety
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bradycardia
Less Severe
- Iritis
Contraindicated
None
Severe Precaution
Brimonidine (Ophth_OTC)
Consult clinician for use in child age < 5 years.
- 1 Day – 5 Years
- Consult clinician for use in child age < 5 years.
Management or Monitoring Precaution
None
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Ocular redness | |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| 0-9 | A-Z |
|---|---|
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
Formulary Reference Tool